Advertisement
Journal Home
Search for

Volume 152, Issue 1, Pages 101-105 (January 2008)


View previous. 39 of 56 View next.

Folate Pathway Genetic Polymorphisms are Related to Attention Disorders in Childhood Leukemia Survivors

Kevin R. Krull, PhDabCorresponding Author Informationemail address, Pim Brouwers, PhDbcd, Neelam Jain, PhDab, Linna Zhang, MDbc, Lisa Bomgaars, MDbc, ZoAnn Dreyer, MDbc, Donald Mahoney, MDbc, Sarah Bottomley, MN, CPNPc, M. Fatih Okcu, MD, MPHbce

Received 7 November 2006; received in revised form 24 April 2007; accepted 29 May 2007. published online 10 October 2007.

Objective

To test the hypothesis that 5,10-methylenetetrahydroreductase (MTHFR) polymorphisms can partially explain the individual variation in developing attention-deficit/hyperactivity disorder (ADHD) after acute lymphoblastic leukemia (ALL) therapy.

Study design

Parents of 48 survivors of childhood ALL completed a clinical diagnostic process to identify subtypes of ADHD. Genotyping was performed with peripheral blood DNA for MTHFR (C677T and A1298C) polymorphisms.

Results

Eleven of the 48 patients (22.9%) had scores consistent with the inattentive symptoms of ADHD. Patients with genotypes related to lower folate levels (11 out of 39; 39.2%) were more likely to have ADHD. The A1298C genotype appeared to be the predominant linkage to the inattentive symptoms, leading to a 7.4-fold increase in diagnosis, compared with a 1.3-fold increase for the C677T genotype. Age at diagnosis and sex were not associated with inattentiveness.

Conclusions

Preliminary data imply a strong relationship between MTHFR polymorphisms and the inattentive symptoms of ADHD in survivors of childhood ALL.

a Learning Support Center for Child Psychology, Texas Children’s Hospital, Houston, TX

b Department of Pediatrics, Baylor College of Medicine, Houston, TX

c Texas Children’s Cancer Center, Houston, TX

d Division of AIDS & Health and Behavior Research, National Institute of Mental Health, Rockville, MD

e Childhood Cancer Epidemiology and Prevention Center, Houston, TX.

Corresponding Author InformationReprint requests: Kevin R. Krull, PhD, Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, 332 N. Lauderdale St, MS 735, Memphis, TN 38105-2794.

 No author reports any conflict of interest associated with this study.

PII: S0022-3476(07)00551-3

doi:10.1016/j.jpeds.2007.05.047


View previous. 39 of 56 View next.

Advertisement